Clinical trials
Active, not recruiting Neoplasms trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Exelixis | 1 |
| Oslo University Hospital | 1 |
| Pfizer | 1 |
| Tampere University Hospital | 1 |
| Tesaro, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 12 |
| Lymphoma | 2 |
| Neoplasms, Plasma Cell | 2 |
| Recurrence | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blood Protein Disorders | 1 |
| Bone Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.